Increased thrombin-activatable fibrinolysis inhibitor and decreased tissue factor pathway inhibitor in patients with hyperthyroidism - Erem,C.; Ucuncu,O.; Yilmaz,M.; Kocak,M.; Nuhoglu,I.; Ersoz,H.O. (Endocrine, 2009)